GoodRx Holdings, Inc. (GDRX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 80M 160M 240M Q3 '19: 101.7M Q4 '19: 113.3M Q1 '20: 133.4M Q2 '20: 123.3M Q3 '20: 140.5M Q4 '20: 153.5M Q1 '21: 160.4M Q2 '21: 176.6M Q3 '21: 195.1M Q4 '21: 213.3M Q1 '22: 203.3M Q2 '22: 191.8M Q3 '22: 187.3M Q4 '22: 184.1M Q1 '23: 184M Q2 '23: 189.7M Q3 '23: 180M Q4 '23: 196.6M Q1 '24: 197.9M Q2 '24: 200.6M Q3 '24: 195.3M Q4 '24: 198.6M Q1 '25: 203M Q2 '25: 203.1M Q3 '25: 196M Q4 '25: 194.8M Q1 '26: 194M Q2 '26: 200.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit Quarterly

0 70M 140M 210M Q3 '19: 94.7M Q4 '19: 104.4M Q1 '20: 123M Q2 '20: 112M Q3 '20: 127.8M Q4 '20: 139.9M Q1 '21: 144.6M Q2 '21: 157.2M Q3 '21: 173.7M Q4 '21: 188.7M Q1 '22: 179.7M Q2 '22: 160.4M Q3 '22: 156M Q4 '22: 151.2M Q1 '23: 152.4M Q2 '23: 157.2M Q3 '23: 128.2M Q4 '23: 137.9M Q1 '24: 169.5M Q2 '24: 171.8M Q3 '24: 166M Q4 '24: 167.3M Q1 '25: 168.7M Q2 '25: 170M Q3 '25: 161.2M Q4 '25: 154.2M Q1 '26: 152.1M Q2 '26: 157.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-300M -150M 0 150M 300M 450M Q3 '19: 37.8M Q4 '19: 35.8M Q1 '20: 43.7M Q2 '20: 41.7M Q3 '20: -61.7M Q4 '20: -299.4M Q1 '21: -5M Q2 '21: -351K Q3 '21: 7M Q4 '21: 11.8M Q1 '22: 19.8M Q2 '22: -4M Q3 '22: -15.7M Q4 '22: 1.7M Q1 '23: 11.3M Q2 '23: 18.3M Q3 '23: -38.3M Q4 '23: -18.3M Q1 '24: 7.4M Q2 '24: 19.9M Q3 '24: 20.4M Q4 '24: 18.2M Q1 '25: 23.4M Q2 '25: 26.8M Q3 '25: 14.6M Q4 '25: 22.7M Q1 '26: 14M Q2 '26: 23.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income Quarterly

-300M -150M 0 150M 300M 450M Q1 '19: 11.6M Q2 '19: 19.6M Q3 '19: 19.6M Q4 '19: 15.2M Q1 '20: 27.3M Q2 '20: 27.3M Q3 '20: -50M Q4 '20: -298.3M Q1 '21: 1.7M Q2 '21: 31.1M Q3 '21: -18.1M Q4 '21: -39.9M Q1 '22: 12.3M Q2 '22: -1.4M Q3 '22: -41.7M Q4 '22: -2M Q1 '23: -3.3M Q2 '23: 58.8M Q3 '23: -38.5M Q4 '23: -25.9M Q1 '24: -1M Q2 '24: 6.7M Q3 '24: 4M Q4 '24: 6.7M Q1 '25: 11.1M Q2 '25: 12.8M Q3 '25: 1.1M Q4 '25: 5.4M Q1 '26: 1.2M Q2 '26: 8.5M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 8M 16M 24M Q3 '19: 3.4M Q4 '19: 4.6M Q1 '20: 6M Q2 '20: 6.8M Q3 '20: 7.5M Q4 '20: 9.2M Q1 '21: 10.4M Q2 '21: 11.1M Q3 '21: 11.3M Q4 '21: 13.9M Q1 '22: 12.3M Q2 '22: 18M Q3 '22: 17.4M Q4 '22: 17.4M Q1 '23: 16.7M Q2 '23: 16.3M Q3 '23: 18.7M Q4 '23: 15.2M Q1 '24: 12.5M Q2 '24: 11.9M Q3 '24: 11.7M Q4 '24: 12.2M Q1 '25: 13.4M Q2 '25: 13.3M Q3 '25: 13.4M Q4 '25: 17.5M Q1 '26: 20.2M Q2 '26: 21M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow Quarterly

0 30M 60M 90M Q4 '19: 16.5M Q1 '20: 45.6M Q2 '20: 38.2M Q3 '20: 32.7M Q4 '20: 14.8M Q1 '21: 45.5M Q2 '21: 34.9M Q3 '21: 48.6M Q4 '21: 49.8M Q1 '22: 30.1M Q2 '22: 51M Q3 '22: 33.7M Q4 '22: 31.9M Q1 '23: 32.3M Q2 '23: 29.9M Q3 '23: 60.3M Q4 '23: 15.9M Q1 '24: 42.6M Q2 '24: 9.7M Q3 '24: 86.9M Q4 '24: 44.7M Q1 '25: 9.4M Q2 '25: 49.6M Q3 '25: 76M Q4 '25: 32.9M Q1 '26: 11.8M Q2 '26: 80.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow Quarterly

0 30M 60M 90M Q4 '19: 16.1M Q1 '20: 44.9M Q2 '20: 37.1M Q3 '20: 18.8M Q4 '20: 10M Q1 '21: 42.8M Q2 '21: 34.6M Q3 '21: 47.9M Q4 '21: 49M Q1 '22: 28.4M Q2 '22: 49.6M Q3 '22: 33.1M Q4 '22: 31.7M Q1 '23: 32.1M Q2 '23: 29.6M Q3 '23: 60.1M Q4 '23: 15.5M Q1 '24: 42.2M Q2 '24: 9.4M Q3 '24: 86.5M Q4 '24: 44.6M Q1 '25: 9.3M Q2 '25: 49.2M Q3 '25: 74.3M Q4 '25: 31.6M Q1 '26: 10.7M Q2 '26: 80.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q3 '19: 231.8M Q1 '20: 236.2M Q2 '20: 236.9M Q3 '20: 241.1M Q1 '21: 429.6M Q2 '21: 428.9M Q3 '21: 411.2M Q1 '22: 427.4M Q2 '22: 412.1M Q3 '22: 413M Q1 '23: 412.4M Q2 '23: 414.3M Q3 '23: 413.4M Q1 '24: 390M Q2 '24: 384.7M Q3 '24: 388.5M Q1 '25: 379.7M Q2 '25: 357.2M Q3 '25: 347.8M Q1 '26: 341.4M Q2 '26: 348.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q2 '20: 0.25 Q3 '20: -0.01 Q4 '20: -1.13 Q1 '21: -1.21 Q2 '21: -1.22 Q3 '21: -1.05 Q4 '21: -0.06 Q1 '22: -0.03 Q2 '22: -0.10 Q3 '22: -0.16 Q4 '22: -0.08 Q1 '23: -0.12 Q2 '23: 0.02 Q3 '23: 0.03 Q4 '23: -0.02 Q1 '24: -0.01 Q2 '24: -0.13 Q3 '24: -0.03 Q4 '24: 0.05 Q1 '25: 0.08 Q2 '25: 0.10 Q3 '25: 0.09 Q4 '25: 0.09 Q1 '26: 0.06 Q2 '26: 0.04 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.